Product Information
MYCOPHENOLATE 200 MG/ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9440 per ML under NDC 59651064626. Its NADAC has been published 72 times since Apr 9, 2025.
FDA first approved this application on Sep 26, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651064626
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA218227FDA Approved
9/26/2024
TE Code
AB
On Market Since
9/26/2024
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 200 MG/ML SUSP has been published 72 times since Apr 9, 2025, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9440 per ML |
|---|---|
| All-time high | $1.7286 (Jul 16, 2025) |
| All-time low | $0.9324 (Jun 17, 2026) |
| 52-week high | $1.5140 |
| 52-week low | $0.9324 |
| Median price | $1.1692 |
| Average price | $1.2802 |
| Largest weekly change | -15.4% (Sep 17, 2025) |
| Weeks tracked | 72 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mycophenolate mofetil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 200 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 200 MG/ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.9440 per ML (NDC 59651064626), effective Aug 19, 2026.
How has the price of MYCOPHENOLATE 200 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has declined 44.0%. It has been tracked across 72 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 200 MG/ML SUSP?
Since Apr 9, 2025, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has ranged from a low of $0.9324 (Jun 17, 2026) to a high of $1.7286 (Jul 16, 2025), with a median of $1.1692 per ML.
Are there cheaper alternatives to MYCOPHENOLATE 200 MG/ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of MYCOPHENOLATE 200 MG/ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MYCOPHENOLATE 200 MG/ML SUSP?
MYCOPHENOLATE 200 MG/ML SUSP (NDC 59651064626) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.